The Biotech Growth Trust PLC Announces Market Purchase of Its Own Shares

The Biotech Growth Trust PLC has issued a notification regarding its market purchase of its own shares. The company has been authorized to make market purchases up to an aggregate maximum of 4,255,299 shares. Recent transactions have seen a total of 470,069 Ordinary shares of 25p each purchased for cancellation at a price of 731.70 pence per share. This update affects the company's issued share capital and voting rights, with the total number of Ordinary shares now standing at 25,445,353.

Key Takeaways:

• The Biotech Growth Trust PLC has purchased a total of 470,069 Ordinary shares at a price of 731.70 pence per share.
• These purchases are part of the company's authorized market purchases up to an aggregate maximum of 4,255,299 shares.
• The total number of Ordinary shares in issue, including those purchased for cancellation, is 25,445,353.
• This is the total number of voting rights in the company and should be used by shareholders to determine if they need to notify their interest under the FCA's Disclosure Guidance and Transparency Rules.
• The company does not currently hold any Ordinary shares in treasury.
• Frostrow Capital LLP serves as the company secretary and contact for further information.

Statistics:

• 470,069 Ordinary shares purchased for cancellation.
• Total price paid per share: 731.70 pence.
• Total number of Ordinary shares in issue: 25,445,353.
• Aggregate maximum number of shares authorized for purchase: 4,255,299.
• Price per share.
• Voting rights in the company: 25,445,353.

Sources:

• PR Newswire For immediate release
• The Biotech Growth Trust PLC (authorization for market purchases)
• Frostrow Capital LLP (contact information as company secretary)